Tempus
North America, Illinois, United States, Chicago
Description
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
Investor Profile
Tempus has backed more than 4 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series A, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Biotechnology, Genetics, Life Science.
- Led 1 rounds in the past year.
Stage Focus
- Series Unknown (50%)
- Series A (25%)
- Post Ipo Equity (25%)
Country Focus
- United States (75%)
- United Kingdom (25%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Genetics
- Life Science
- Therapeutics
- Health Care
- Neuroscience
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
